PhRMA Challenges FDA Proposed DTC Guidelines

[Pharma Newshound]

In a 20-page comment submitted to the FDA on May 14, 2012, the Pharmaceutical Research and Manufacturers of America (PhRMA), advised the FDA to "proceed cautiously and in a manner that fully protects the free speech rights of advertisers and patients" with regard to the agency's recent Draft Guidance for Industry on Direct-to-Consumer (DTC) Television Advertisements."

[See Pharma Marketing Blog post: "PhRMA Demands that FDA 'Cabin' Its Discretion to Regulate DTC Ads"]

See attached PDF for PhRMA's comments.